Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer’s disease

Brain, Behavior, and Immunity - Tập 107 - Trang 225-241 - 2023
Mandy S.J. Kater1, Christiaan F.M. Huffels2, Takuya Oshima3, Niek S. Renckens2, Jinte Middeldorp2,4, Erik W.G.M. Boddeke3,5, August B. Smit1, Bart J.L. Eggen3, Elly M. Hol2, Mark H.G. Verheijen1
1Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
2Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands
3Department of Biomedical Sciences of Cells & Systems, Section Molecular Neurobiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
4Department of Neurobiology & Aging, Biomedical Primate Research Centre, Rijswijk, The Netherlands
5Center for Healthy Ageing, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark

Tài liệu tham khảo

Aarts, 2015, The light spot test: measuring anxiety in mice in an automated home-cage environment, Behav. Brain Res., 294, 123, 10.1016/j.bbr.2015.06.011 Antonenko, 2010, Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels, J. Bioenerg. Biomembr., 42, 151, 10.1007/s10863-010-9271-1 Berens, 2020, Minocycline differentially modulates human spatial memory systems, Neuropsychopharmacology, 45, 2162, 10.1038/s41386-020-00811-8 Bessis, 2007, Microglial control of neuronal death and synaptic properties, Glia, 55, 233, 10.1002/glia.20459 Biscaro, 2012, Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for alzheimer's disease, Neurodegenerative Diseases, 9, 187, 10.1159/000330363 Blum, 2004, Clinical potential of minocycline for neurodegenerative disorders, Neurobiol. Disease, 17, 359, 10.1016/j.nbd.2004.07.012 Çetereisi, 2019, Gpr158 deficiency impacts hippocampal CA1 neuronal excitability, dendritic architecture, and affects spatial learning, Front. Cell. Neurosci., 13 Choi, 2007, Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models, Neuropsychopharmacology, 32, 2393, 10.1038/sj.npp.1301377 Corbett, 2012, Drug repositioning for Alzheimer's disease, Nat. Rev. Drug Discov., 11, 833, 10.1038/nrd3869 D'Amelio, 2011, Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease, Nat. Neurosci., 14, 69, 10.1038/nn.2709 De Strooper, 2016, The cellular phase of Alzheimer's disease, Cell, 164, 603, 10.1016/j.cell.2015.12.056 Deacon, 2006, Assessing nest building in mice, Nat. Protoc., 1, 1117, 10.1038/nprot.2006.170 Deacon, 2014, A novel approach to discovering treatments for Alzheimer’s Disease, J. Alzheimer's Disease Parkinsonism, 4 Deacon, 2002, Hippocampal cytotoxic lesion effects on species-typical behaviours in mice, Behav. Brain Res., 132, 203, 10.1016/S0166-4328(01)00401-6 Deacon, 2008, Age-dependent and -independent behavioral deficits in Tg2576 mice, Behav. Brain Res., 189, 126, 10.1016/j.bbr.2007.12.024 Ding, 2008, Retinoic acid attenuates β-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model, J. Neurosci., 28, 10.1523/JNEUROSCI.3153-08.2008 Distrutti, 2014, Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP, PLoS ONE, 9, e106503, 10.1371/journal.pone.0106503 Dubbelaar, 2018, The kaleidoscope of microglial phenotypes, Front. Immunol., 9 El-Shimy, 2015, Minocycline attenuates Aβ oligomers-induced pro-inflammatory phenotype in primary microglia while enhancing Aβ fibrils phagocytosis, Neurosci. Lett., 609, 36, 10.1016/j.neulet.2015.10.024 Familian, 2006, Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation, Glia, 53, 233, 10.1002/glia.20268 Fan, 2007, Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid, J. Neurosci., 27, 3057, 10.1523/JNEUROSCI.4371-06.2007 Ferretti, 2012, Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology, J. Neuroinflammation, 9 Filali, 2009, Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease, Genes, Brain and Behavior, 8, 143, 10.1111/j.1601-183X.2008.00453.x Ganz, 2018, Neuropathology and cognitive performance in self-reported cognitively healthy centenarians, Acta Neuropathol. Commun., 6, 64, 10.1186/s40478-018-0558-5 Gaskill, 2013, Nest building as an indicator of health and welfare in laboratory mice, J. Visualized Experiments, 82, e51012 Gerrits, 2021, Distinct amyloid-beta and tau-associated microglia profiles in Alzheimer's disease, Acta Neuropathol., 141, 681, 10.1007/s00401-021-02263-w Gomez-Nicola, 2015, Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity, Neuroscientist, 21, 169, 10.1177/1073858414530512 Griffin, 2006, The age-related attenuation in long-term potentiation is associated with microglial activation, J. Neurochem., 99, 1263, 10.1111/j.1471-4159.2006.04165.x Hammond, 2018, Microglia and the brain: complementary partners in development and disease, Annu. Rev. Cell Dev. Biol., 34, 523, 10.1146/annurev-cellbio-100616-060509 Hijazi, S., Heistek, T. S., Scheltens, P., Neumann, U., Shimshek, D. R., Mansvelder, H. D., Smit, A. B., & van Kesteren, R. E. (2019). Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease. Molecular Psychiatry, 25, 3380-3398. doi: 10.1038/s41380-019-0483-4. Holtman, 2015, Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis, Acta Neuropathol. Commun., 3, 31, 10.1186/s40478-015-0203-5 Hong, 2016, Complement and microglia mediate early synapse loss in Alzheimer mouse models, Science, 352, 712, 10.1126/science.aad8373 Howard, 2020, Minocycline at 2 different dosages vs placebo for patients with mild Alzheimer disease: a randomized clinical trial, JAMA Neurol., 77, 164, 10.1001/jamaneurol.2019.3762 Huang, 2021, Microglia use TAM receptors to detect and engulf amyloid beta plaques, Nat. Immunol., 22, 586, 10.1038/s41590-021-00913-5 Huffels, 2022, Amyloid-beta plaques affect astrocyte Kir4.1 protein expression but not function in the dentate gyrus of APP/PS1 mice, Glia, 70, 748, 10.1002/glia.24137 Jacobsen, 2006, Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease, PNAS, 103, 5161, 10.1073/pnas.0600948103 Jankowsky, 2004, APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1, Neurobiol. Aging, 25, 885, 10.1016/j.neurobiolaging.2003.09.008 Kamphuis, 2012, Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model, Glia, 60, 615, 10.1002/glia.22295 Kamphuis, 2016, Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease, Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids, 1862, 1847, 10.1016/j.bbadis.2016.07.007 Kettenmann, 2013, Microglia: new roles for the synaptic stripper, Neuron, 77, 10, 10.1016/j.neuron.2012.12.023 Ladner, 2004, Visible fluorescent detection of proteins in polyacrylamide gels without staining, Anal. Biochem., 326, 13, 10.1016/j.ab.2003.10.047 Lee, 2010, The role of microglia in amyloid clearance from the AD brain, J Neural Transm, 117, 949, 10.1007/s00702-010-0433-4 Leyh, 2021, Classification of Microglial Morphological Phenotypes Using Machine Learning, Front. Cell. Neurosci., 15, 10.3389/fncel.2021.701673 Liu, M. C., Liu, X. Q., Wang, W., Shen, X. F., Che, H. L., Guo, Y. Y., Zhao, M. G., Chen, J. Y., & Luo, W. J. (2012). Involvement of Microglia Activation in the Lead Induced Long-Term Potentiation Impairment. PLoS ONE, 7(8). 10.1371/journal.pone.0043924. Malm, 2008, Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease, Glia, 56, 1767, 10.1002/glia.20726 Marchetti, 2011, Hippocampal synaptic plasticity in Alzheimer's disease: What have we learned so far from transgenic models?, Rev. Neurosci., 22, 373, 10.1515/rns.2011.035 Mattei, 2017, Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment, Transl. Psychiatry, 7, e1120, 10.1038/tp.2017.80 Meijering, 2001, Quantitative evaluation of convolution-based methods for medical image interpolation, Med. Image Anal., 5, 111, 10.1016/S1361-8415(00)00040-2 Merino-Serrais, 2011, Layer-specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease, Hippocampus, 21, 1037, 10.1002/hipo.20861 Merluzzi, 2018, Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia, Neurology, 91, E436, 10.1212/WNL.0000000000005901 Mohle, 2016, Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis, Cell Rep., 15, 1945, 10.1016/j.celrep.2016.04.074 Neely, 2019, Nest building behavior as an early indicator of behavioral deficits in mice, J. Visualized Experiments, 152, e60139 Nutile-McMenemy, 2007, Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression, J. Neurochem., 103, 2035, 10.1111/j.1471-4159.2007.04889.x Orre, 2014, Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction, Neurobiol. Aging, 35, 2746, 10.1016/j.neurobiolaging.2014.06.004 Paolicelli, 2011, Synaptic pruning by microglia is necessary for normal brain development, Science, 333, 1456, 10.1126/science.1202529 Parachikova, 2010, Reductions in amyloid-β-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation, J. Alzheimers Dis., 21, 527, 10.3233/JAD-2010-100204 Perez-Nievas, 2013, Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology, Brain, 136, 2510, 10.1093/brain/awt171 Querfurth, 2010, Alzheimer's disease, N. Engl. J. Med., 362, 329, 10.1056/NEJMra0909142 Rebola, 2011, Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction, J. Neurochem., 117, 100, 10.1111/j.1471-4159.2011.07178.x Risher, 2014, Rapid golgi analysis method for efficient and unbiased classification of dendritic spines, PLoS ONE, 9, e107591, 10.1371/journal.pone.0107591 Sasaguri, 2017, APP mouse models for Alzheimer's disease preclinical studies, EMBO J., 36, 2473, 10.15252/embj.201797397 Schafer, 2012, Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner, Neuron, 74, 691, 10.1016/j.neuron.2012.03.026 Scheff, 2006, Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment, Neurobiol. Aging, 27, 1372, 10.1016/j.neurobiolaging.2005.09.012 Schmidtner, 2019, Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner, Transl. Psychiatry, 9, 223, 10.1038/s41398-019-0556-9 Seabrook, 2006, Minocycline Affects Microglia Activation, Aβ Deposition, and Behavior in APP-tg Mice, Glia, 53, 776, 10.1002/glia.20338 Shi, 2017, Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice, Sci. Transl. Med., 9, 10.1126/scitranslmed.aaf6295 Shippy, 2020, Microglial immunometabolism in Alzheimer’s disease, Front. Cell. Neurosci., 14 Smit, 2021, Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the APPswePS1dE9 mouse model, Glia, 69, 1852, 10.1002/glia.23981 Terry, 1991, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol., 30, 572, 10.1002/ana.410300410 Tremblay, 2011, The role of microglia in the healthy brain, J. Neurosci., 31, 16064, 10.1523/JNEUROSCI.4158-11.2011 Van Tijn, 2012, Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease, Neurochem. Int., 61, 739, 10.1016/j.neuint.2012.07.007 Végh, 2014, Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer's disease, Acta Neuropathol. Commun., 2 Volianskis, 2010, Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis, Neurobiol. Aging, 31, 1173, 10.1016/j.neurobiolaging.2008.08.005 Wang, 2015, Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease, Ann. Transl. Med., 3 Wang, 2005, β-Amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor, Eur. J. Neurosci., 22, 2827, 10.1111/j.1460-9568.2005.04457.x Wang, 2020, Microglia mediate forgetting via complement-dependent synaptic elimination, Science, 367, 688, 10.1126/science.aaz2288 Weggen, 2003, Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity, J. Biol. Chem., 278, 31831, 10.1074/jbc.M303592200 Westerman, 2002, The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease, J. Neurosci., 22, 1858, 10.1523/JNEUROSCI.22-05-01858.2002 Wightman, 2021, A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease, Nat. Genet., 53, 1276, 10.1038/s41588-021-00921-z Woo, 2015, Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers, Cell Death Differ., 22, 921, 10.1038/cdd.2015.5 Yong, 2004, The promise of minocycline in neurology, Lancet Neurol., 3, 744, 10.1016/S1474-4422(04)00937-8 Zhang, 2021, Intrinsic DNA damage repair deficiency results in progressive microglia loss and replacement, Glia, 69, 729, 10.1002/glia.23925 Zhu, 2017, The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease, CNS Neurosci. Ther., 23, 310, 10.1111/cns.12677